Joseph W. Lewcock PhD

Denali Therapeutics

Appearances

Therapeutic Strategies for the Treatment of Neurodegenerative Disease Based on Human Genetics
Date
June 7, 2021
Speaker
Joseph W. Lewcock, PhD
Denali Therapeutics
[Joint Session] Disease Mechanisms and Therapeutic Targets
Date
June 7, 2021
Co-Chairs
Joseph W. Lewcock, PhD
Denali Therapeutics
Kate Monroe, PhD
Denali Therapeutics
From Therapeutic Targets to Clinic
Date
June 7, 2021
Co-Chairs
Joseph W. Lewcock, PhD
Denali Therapeutics
Charlotte J. Sumner, MD
Johns Hopkins School of Medicine

Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.